Lyse Santoro
Directeur Général chez OVVI Diagnostics France SE
Profil
Lyse Santoro is currently the Chief Executive Officer at OVVI Diagnostics France SE since 2012.
Prior to this, she worked as a Director at Quantum Genomics SA.
Postes actifs de Lyse Santoro
| Sociétés | Poste | Début |
|---|---|---|
OVVI Diagnostics France SE
 OVVI Diagnostics France SE Miscellaneous Commercial ServicesCommercial Services OVVI Diagnostics France SE develops diagnostic tests for cardiovascular diseases. The firm’s technology include MIAtek technology, MIAplex technology and instruments for emergency diagnostic test for cardio-vascular diseases. The company was founded by Petr Nikitin, Jean-Patrick Voisin and Daniel Bernard in 2003 and is headquartered in Paris, France. | Directeur Général | 01/01/2012 |
Anciens postes connus de Lyse Santoro
| Sociétés | Poste | Fin |
|---|---|---|
| QUANTUM GENOMICS | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QUANTUM GENOMICS | Health Technology |
| Entreprise privées | 1 |
|---|---|
OVVI Diagnostics France SE
OVVI Diagnostics France SE Miscellaneous Commercial ServicesCommercial Services OVVI Diagnostics France SE develops diagnostic tests for cardiovascular diseases. The firm’s technology include MIAtek technology, MIAplex technology and instruments for emergency diagnostic test for cardio-vascular diseases. The company was founded by Petr Nikitin, Jean-Patrick Voisin and Daniel Bernard in 2003 and is headquartered in Paris, France. | Commercial Services |
